Imagine if heart failure care worked like cancer care, where comfort and quality of life are prioritized alongside medicine. This project creates a digital tool that lets patients track their symptoms and spiritual needs from home. It helps doctors catch problems early so patients can stay out of the hospital and feel more in control of their lives.
Heart failure patients suffer from untreated symptoms and spiritual concerns because palliative care is often only introduced at the very end of life. This leads to avoidable emergency hospitalisations and higher healthcare costs.
The PAL@HEART application for home monitoring of symptoms and a proactive, patient-centered care plan for heart failure pathways.
If you are a mHealth app developer dealing with low patient engagement in chronic care — this project developed the PAL@HEART application that monitors multidimensional symptoms at home. This allows for faster identification of needs and better communication between patients and providers.
If you are a private hospital group dealing with high readmission rates for heart failure — this project developed a proactive care plan and monitoring system that reduces emergency hospitalisations. This unburdens the healthcare system and lowers operational costs.
If you are a medical insurance provider dealing with the high cost of end-of-life emergency care — this project developed a validated cost-effective care approach. By integrating palliative care earlier, it reduces expensive emergency interventions.
Based on available project data, specific pricing is not mentioned, but the project aims to demonstrate cost-effectiveness by reducing emergency hospitalisations.
Yes, the project is testing and validating the approach across 7 EU countries, the UK, and Switzerland to ensure it works in a broad European context.
Based on available project data, specific licensing terms are not provided; however, the project is led by UMC Utrecht with 15 other partners.
The approach is designed to be integrated directly into existing heart failure care pathways, using a patient-centered proactive care plan.
The project period runs from 2024-01-01 to 2028-12-31, suggesting full validation will be complete by the end of 2028.
The consortium is heavily academic, consisting of 12 universities and 2 research institutes across 10 countries. With 0% industry representation and 0 SMEs, the project is currently driven by clinical and scientific validation rather than commercial interests, suggesting a high need for future industry partnerships to bring the PAL@HEART app to market.
Contact Universitaire Medisch Centrum Utrecht
Contact us to bridge the gap between this clinical research and your digital health product roadmap.
